About Protean Biodiagnostics
Protean Biodiagnostics is a private company based in Orlando, Florida. It has reported $1,759,500 raised in four offerings on Form D since June 2019.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Not yet | Dec 7, 2023 | $0of $6.0M target | 0 | — | Simple Agreement for Future EquityRule 506(b) | Form D ↗ |
| Not yet | May 18, 2021 | $1,429,500of $1.7M target | 12 | $119K | EquityRule 506(b) | Form D ↗ |
| Not yet | Jan 4, 2021amended May 14, 2021 | $0of $1.5M target | 0 | — | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 4, 2019 | Jun 27, 2019 | $330,000of $800K target | 4 | $82,500 | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $1,759,500 | |||||
The filing for the offering first filed May 18, 2021 reports amount sold but first sale marked as not yet made. Figures are shown as filed.
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Protean Biodiagnostics's Form D filed Dec 7, 2023.
RI
Ronen Israel
Director
FM
Frank Morsani
Director
SL
Susan Lee
Executive officer
AC
Anees Chagpar
Director
VJ
Violet Jameson
Director
AM
Anthony Magliocco
Executive officer and director